| Characteristic | Drugs (Biotechnology) | Heathcare Information and Technology | Healthcare Products | Drugs (Pharmaceutical) | Hospitals/Healthcare Facilities | Healthcare Support Services |
|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Source
Release date
January 2026
More information
Region
Worldwide
Survey time period
2019 to 2026
Supplementary notes
Values are as of January each year.
A total of 4,504 companies were included in the calculation for 2025, 4,545 for 2024, 4,653 for 2023, 4,579 for 2022, 4,326 for 2021, 4,023 for 2020 and 3,779 for 2019.Â
Enterprise value = Market value of equity + Market value of debt - Cash.
EBITDA = Estimated by adding depreciation and amortization back to operating income (EBIT).
Only positive EBITDA companies.
Figures for years 2019 to 2024 were previously published by the source.
Citation formats
